2-Bromo-1-(pyridazin-4-yl)ethanone

Catalog No.: 
ACTOJC563
CAS No.: 
1211541-01-3
Molecular Formula: 
C6H5BrN2O
Molecular Weight: 
201.02
2-Bromo-1-(pyridazin-4-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$202.00InquiryInquiry
250mg97%$369.00InquiryInquiry
1g97%$1071.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-1-(pyridazin-4-yl)ethanone
IUPAC Name2-bromo-1-(pyridazin-4-yl)ethan-1-one
MDL No.MFCD26929932
Molecular FormulaC6H5BrN2O
Molecular Weight201.02
SMILESO=C(C1=CC=NN=C1)CBr
InChI KeyRTSIVSRCDLXBMQ-UHFFFAOYSA-N
SynonymEthanone, 2-bromo-1-(4-pyridazinyl)-;2-Bromo-1-(pyridazin-4-yl)ethanone
CAS No.1211541-01-3
PubChem CID104673202

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACTOJC563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLYED164 route compound structure diagram
    ACLYED16450901-46-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTOJC563 route product structure diagram
    ACTOJC5631211541-01-3
Inquiry

2. ACTOJC563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTOJC563 route product structure diagram
    ACTOJC5631211541-01-3
Inquiry

3. ACTOJC563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTOJC563 route product structure diagram
    ACTOJC5631211541-01-3
Inquiry

Comments (0)